Clinical trial · Observational
Multicentric and Retrospective Analysis of Adolescent Young Adult (AYA) Hodgkins' Lymphoma Patients
Valutazione Retrospettiva Multicentrica e Risultati Delle Strategie Terapeutiche Nei Pazienti Adolescenti o Giovani Adulti (AYA). Studio di Collaborazione Fra AIEOP e FIL
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The principal aim of this study is to collect retrospectively all Adolescent Young Adult patients affected by Hodgkin's Lymphoma and treated in pediatric or adult haemato-oncology Centers. The data set collection aims to define the therapy performed and the results obtained in terms of overall survival and acute or late complications.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adolescent Behavior | — | UNRESOLVED | — |
| Chemotherapy Effect | — | UNRESOLVED | — |
| Hodgkin Lymphoma | Hodgkin Lymphoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Description of therapeutical results | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- AIEOP
- description
- This is a National Association for the treatment of pediatric patients with hematological or oncological disease
- interventionNames
- Behavioral: Description of therapeutical results
- label
- FIL
- description
- This is a National Association that brings together many centers with particular attention to the treatment of adult lymphomas
- interventionNames
- Behavioral: Description of therapeutical results
Primary outcomes (1)
- measure
- Overall survival according to different treatment.
- timeFrame
- 2004 to 2016
- description
- To evaluate if there are differences in treatment of pediatric or adult subset of patients
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
- Maximum age
- 24 Years
Show eligibility criteria text
Inclusion Criteria: * All consecutive patients with diagnosis of Hodgkin Lymphoma with an age at diagnosis ranging between 15 and 24 years enrolled in prospective studies either in AIEOP group and in FIL group or patients treated consecutively in single centers affiliated to AIEOP or FIL and registered in single institutional data base. * All Hodgkin subtype Exclusion Criteria: * None
References
Publications (0)
Data not yet available